Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (10)
Mucosal Immunology (2)
Leukemia (1)
Bone Marrow Transplantation (1)
Nature Reviews Clinical Oncology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (15)
Comments & Opinion (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biomarkers
Cancer
Cell biology
Chemical biology
Diseases
Gastroenterology
Health care
Immunology
Medical research
Oncology
Urology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–17 of 17 results

Advanced filters: Author: G Bamias Clear advanced filters

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

N G Gavalas
M Tsiatas
A Bamias
ResearchOpen Access20 Nov 2012
British Journal of Cancer

Volume: 107, P: 1869-1875
Do elderly patients have a worse outcome in response to platinum-based therapy for metastatic urothelial cancer?

Supriya G Mohile
Walter M Stadler
Comments & Opinion01 Aug 2005
Nature Clinical Practice Oncology

Volume: 2, P: 392-393
Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

K S Han
J Y Joung
K H Lee
ResearchOpen Access18 Dec 2007
British Journal of Cancer

Volume: 98, P: 86-90
Osteopontin is a marker for cancer aggressiveness and patient survival

G F Weber
G S Lett
N C Haubein
ResearchOpen Access07 Sept 2010
British Journal of Cancer

Volume: 103, P: 861-869
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration

A Bamias
K Tzannis
C Bamia
ResearchOpen Access27 Jun 2013
British Journal of Cancer

Volume: 109, P: 332-341
Construction, characterisation and kinetics of a single chain antibody recognising the tumour associated antigen placental alkaline phosphatase

P Savage
G Rowlinson-Busza
AA Epenetos
Research01 Oct 1993
British Journal of Cancer

Volume: 68, P: 738-742
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse

S F Hain
M J O'Doherty
R A Huddart
ResearchOpen Access05 Sept 2000
British Journal of Cancer

Volume: 83, P: 863-869
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma

A Corso
M Varettoni
M Lazzarino
Research05 Apr 2007
Leukemia

Volume: 21, P: 1545-1548
Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab

Lorena Incorvaia
Sarah Scagliarini
Matteo Santoni
ResearchOpen Access14 Mar 2025
Scientific Reports

Volume: 15, P: 1-9
Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model

G Rowlinson-Busza
A Maraveyas
AA Epenetos
Research01 Apr 1995
British Journal of Cancer

Volume: 71, P: 660-665
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial

C Papadimitriou
U Dafni
M A Dimopoulos
Research19 Nov 2007
Bone Marrow Transplantation

Volume: 41, P: 547-554
ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival

A Brüning-Richardson
J Bond
S M Bell
ResearchOpen Access19 Apr 2011
British Journal of Cancer

Volume: 104, P: 1602-1610
A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice

In this Consensus Statement, a global multidisciplinary panel of experts provides recommendations for the definitions, diagnosis and management of patients with fibrostenosing small bowel Crohn’s disease.

Dominik Bettenworth
Mark E. Baker
Florian Rieder
Reviews03 Jun 2024
Nature Reviews Gastroenterology & Hepatology

Volume: 21, P: 572-584
First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC

J J Ko
T K Choueiri
D Y C Heng
ResearchOpen Access01 Apr 2014
British Journal of Cancer

Volume: 110, P: 1917-1922
KLF6 contributes to myeloid cell plasticity in the pathogenesis of intestinal inflammation

W A Goodman
S Omenetti
G H Mahabeleshwar
Research03 Feb 2016
Mucosal Immunology

Volume: 9, P: 1250-1262
Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications

H Gakiopoulou
P Korkolopoulou
E Patsouris
ResearchOpen Access16 Oct 2007
British Journal of Cancer

Volume: 97, P: 1124-1134
Sphingosine-1-phosphate receptor-1 (S1P₁) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease

T Karuppuchamy
E-h Behrens
J Rivera-Nieves
Research06 Apr 2016
Mucosal Immunology

Volume: 10, P: 162-171